Luncheon Meeting with Management to be held in San Francisco on January 12 hosted by Oppenheimer.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IMRX:
- Immuneering to announce OS data from Phase 2a trial of atebimetinib, mGnP
- Immuneering on track to dose first patient in pancreatic cancer trial in 2026
- Immuneering to be added to the Nasdaq Biotechnology Index
- Immuneering Corp. Shines in Positive Earnings Call
- Promising Potential of Immuneering’s Atebimetinib: Analyst Recommends ‘Buy’ Rating